Sanofi’s bad, aw­ful, ter­ri­ble de­vel­op­ment week ends with PhI­II C. diff fail­ure

Fri­day marks the end of Sanofi’s bad, aw­ful, ter­ri­ble week of vac­cine de­vel­op­ment news.

The phar­ma gi­ant $SNY says it will ter­mi­nate its late-stage pro­gram …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.